Q1 2022 Holdings
Filed 2022-05-13 | 37 holdings | $120.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology, Inc.(CGEM) | Common | 230031106 | $80.1M | 7,648,268 | 66.5% |
| Biocryst Pharmaceuticals Inc.(BCRX) | Common | 09058V103 | $10.4M | 639,089 | 8.6% |
| Cytokinetics Inc.(CYTK) | Common | 23282W605 | $8.3M | 224,246 | 6.9% |
| Crinetics Pharmaceuticals Inc.(CRNX) | Common | 22663K107 | $8.0M | 366,676 | 6.7% |
| Arcutis Biotherapeutics inc(ARQT) | Common | 03969K108 | $5.0M | 258,500 | 4.1% |
| Axsome Therapeutics Inc.(AXSM) | Common | 05464T104 | $4.1M | 99,834 | 3.4% |
| Acadia Pharmaceuticals Inc(ACAD) | Common | 004225108 | $3.7M | 151,750 | 3.1% |
| Black Diamond Therapeutics, Inc.(BDTX) | Common | 09203E105 | $664.0K | 239,888 | 0.6% |
| iTeos Therapeutics, Inc.(5E7) | Common | 46565G104 | $56.2K | 1,745,943 | 0.0% |
| Merus N.V. | Common | N5749R100 | $24.3K | 919,482 | 0.0% |
| Repare Therapeutics, Inc.(RPTX) | Common | 760273102 | $23.4K | 1,639,849 | 0.0% |
| Harpoon Therapeutics, Inc. | Common | 41358P106 | $15.9K | 3,196,707 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $11.6K | 159,409 | 0.0% |
| Werewolf Therapeutics, Inc.(HOWL) | Common | 95075A107 | $10.5K | 2,388,011 | 0.0% |
| Turning Point Therapeutics, Inc. | Common | 90041T108 | $9.4K | 351,350 | 0.0% |
| Tcr2 Therapeutics, Inc. | Common | 87808K106 | $9.3K | 3,370,982 | 0.0% |
| Geron Corporation(GERN) | Common | 374163103 | $8.4K | 6,149,277 | 0.0% |
| Travere Therapeutics Inc.(TVTX) | Common | 89422G107 | $7.2K | 277,950 | 0.0% |
| Harmony Biosciences Hldgs Inc.(HRMY) | Common | 413197104 | $6.7K | 137,517 | 0.0% |
| G1 Therapeutics, Inc.(GTHXEUR) | Common | 3621LQ109 | $6.5K | 856,798 | 0.0% |
| Mirum Pharmaceuticals Inc.(MIRM) | Common | 604749101 | $6.4K | 288,531 | 0.0% |
| Reata Pharmaceuticals inc(RETAEUR) | Common | 75615P103 | $5.9K | 180,000 | 0.0% |
| YmAbs Therapeutics, Inc.(YMABUSD) | Common | 984241109 | $5.3K | 443,702 | 0.0% |
| ADC Therapeutics, Inc.(ADCT) | Common | H0036K147 | $4.9K | 334,384 | 0.0% |
| Amicus Therapeutics Inc.(FOLD) | Common | 03152W109 | $4.7K | 495,603 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $4.6K | 3,244,650 | 0.0% |
| Oncorus, Inc. | Common | 68236R103 | $4.2K | 2,377,031 | 0.0% |
| Essa Pharma, Inc.(EPIEUR) | Common | 29668H708 | $4.1K | 660,892 | 0.0% |
| Epizyme, Inc.(EPZMEUR) | Common | 29428V104 | $3.9K | 3,425,202 | 0.0% |
| Revolution Medicines, Inc.(RVMD) | Common | 76155X100 | $3.7K | 146,041 | 0.0% |
| Relmada Therapeutics inc(RLMD) | Common | 75955J402 | $3.7K | 138,000 | 0.0% |
| Avadel Pharmaceuticals Plc | ADR | 05337M104 | $2.8K | 412,363 | 0.0% |
| Phathom Pharmaceuticals inc(PHAT) | Common | 71722W107 | $2.6K | 193,326 | 0.0% |
| Karuna Therapeutics inc | Common | 48576A100 | $2.5K | 20,000 | 0.0% |
| Neogenomics Inc.(NEO) | Common | 64049M209 | $1.6K | 135,573 | 0.0% |
| Inozyme Pharma Inc. | Common | 45790W108 | $1.2K | 294,980 | 0.0% |
| Avrobio, Inc. | Common | 05455M100 | $855 | 647,918 | 0.0% |